MedMira Inc. announces the expansion of its VYRA product line by launching its VYRA CoV2Flu Rapid Antigen Rapid Test (VYRA™ CoV2Flu). Based on MedMira’s...
Valneva SE ,a specialty vaccine company, announced positive topline results from the lot-to-lot Phase 3 trial of its single-shot chikungunya vaccine candidate, VLA1553. The...
IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, announces that IMCD Australia & New Zealand have signed an agreement...
Novartis announced that it entered into a definitive agreement to acquire all of the outstanding share capital of the UK-based ocular gene therapy company...
Crédit Agricole Consumer Finance has affirmed its strategic ambition to develop car financing and encourage new forms of mobility, in line with the Crédit...
